CagriSema vs Tirzepatide: 23% Weight Loss in Phase 3 Trial US$ 28.84 Min. order: 1 piece ★★★★★ 4.1 (266 reviews) Sold : Login>>
Novo Nordisk shares higher on positive Phase 3 trial results for obesity drug Cagrilintide US$ 29.44 Min. order: 1 piece ★★★★★ 4.6 (262 reviews) Sold : Login>>
Think twice before injecting peptides bought online: unauthorized products can seriously harm you US$ 21.16 Min. order: 1 piece ★★★★★ 4.3 (145 reviews) Sold : Login>>
Novo Nordisk files for FDA approval for CagriSema, the first once-weekly combination of GLP‑1 and amylin analogues US$ 23.01 Min. order: 1 piece ★★★★★ 5.0 (109 reviews) Sold : Login>>